Table 1.

Ongoing pharmacological therapies in patients with postprandial distress syndrome (group A) or epigastric pain syndrome (group B), assessed at enrolment.

	Study group
	A		B
	n = 1357		n = 1319
Ongoing pharmacological therapy	n	%	n	%
Proton-pump inhibitors	337	24.8	393	29.8
Prokinetics	173	12.7	71	5.4
Antacids	139	10.2	196	14.9
Sucralfate	22	1.6	34	2.6
Other	27	1.9	31	2.4
Combination	85	6.3	134	10.1
No pharmacological therapy	574	42.3	460	34.9